Tyrosine kinase inhibitorFDA-approvedFirst-line
Midostaurin
How it works
Blocks the activity of certain enzymes that help cancer cells grow and divide.
Cancer types
Leukemia— FLT3-mutated
Efficacy
Studies show that midostaurin can improve overall survival in around 20% of FLT3-mutated patients with acute myeloid leukemia.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.